Nav: Home

Ending needless chemotherapy for breast cancer

June 28, 2019

A diagnostic test developed at The University of Queensland might soon determine if a breast cancer patient requires chemotherapy or would receive no benefit from this gruelling treatment.

Breast cancer survivor Joy Jensen said such a test would give control back to those who felt helpless about their situation.

"If an oncologist could look at test results and say, 'we don't believe you would benefit from chemotherapy', then it would have been nice to be given this choice," Ms Jensen said.

Diagnosed with high-grade invasive lobular breast cancer in June 2014, Ms Jensen underwent a mastectomy, chemotherapy, radiation and hormone therapy.

"I am a full-time worker and a mother of two teenage boys," she said.

"If I could have skipped anything in my treatment which would not have impacted my outcome, it would have been chemotherapy."

UQ Centre for Clinical Research scientist Dr Amy McCart Reed said the test could result in tailored treatment for those diagnosed with invasive lobular breast cancer.

"Using gene profiling, we can identify which patients are unlikely to need chemotherapy," Dr McCart Reed said.

"It means we could protect a significant amount of patients from enduring needless chemotherapy."

Invasive lobular breast cancer is the second most common type of breast cancer with 2000 Australian women diagnosed every year.

Although patients initially respond well to treatment, they often return years later with a terminal spread of the disease.

"It is very hard to tell at diagnosis which patients will do well from those who will not be so lucky, which means chemotherapy may be prescribed," Dr McCart Reed said.

"In this study, we pulled together a set of 194 genes that, when working together, act as a signature to help clarify which patients are likely to have a positive outcome with their breast cancer.

"If they have a low-risk signature score, it means we might relieve them of the burden of chemotherapy.

"If they have a high-risk signature score, we could continue to recommend chemotherapy as the course of treatment.

"In our lab, we are trying to work towards precision oncology and do our best to match people to treatments that will work for them."

Joy Jenson said having a test like this available at diagnosis would bring hope and a brighter future to women like her.

"This research is a positive step forward and one which empowers oncologists and patients to have control over their treatment," Ms Jensen said.
-end-
This research is published in npj Breast Cancer (DOI:10.1038/s41523-019-0113-y).

Media: Dr Amy McCart Reed, amy.reed@uq.edu.au; Faculty of Medicine Communications, med.media@uq.edu.au, +61 7 3365 5118, +61 436 368 746.

University of Queensland

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Sound And Silence
Sound surrounds us, from cacophony even to silence. But depending on how we hear, the world can be a different auditory experience for each of us. This hour, TED speakers explore the science of sound. Guests on the show include NPR All Things Considered host Mary Louise Kelly, neuroscientist Jim Hudspeth, writer Rebecca Knill, and sound designer Dallas Taylor.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

Kittens Kick The Giggly Blue Robot All Summer
With the recent passing of Ruth Bader Ginsburg, there's been a lot of debate about how much power the Supreme Court should really have. We think of the Supreme Court justices as all-powerful beings, issuing momentous rulings from on high. But they haven't always been so, you know, supreme. On this episode, we go all the way back to the case that, in a lot of ways, started it all.  Support Radiolab by becoming a member today at Radiolab.org/donate.